TrialOrphanet journal of rare diseases2024

Pozelimab for CHAPLE disease: results from in-trial interviews and clinical outcome assessments.

Leighann Litcher-Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.